The short answer
New York is the second-largest US venture market and has unusual sector depth. Carta's 2025 ecosystem analysis says New York companies raised 14% of US startup capital on its platform, including 48.5% of fintech funding, while the city also ranked first in healthtech and remained strong in AI and SaaS. The founder advantage is density: investors, customers, operators, and financial institutions sit in the same market. The 15 investors below are a fit-focused starting set, not a prestige ranking or proof that every firm is currently deploying.
Who this list is for
This guide is for founders building in New York or using the city as a meaningful customer, talent, or regulated-market base. It covers firms from pre-seed specialists through multi-stage platforms, so it is most useful after you define the round size and whether you need a lead. A Manhattan office alone is not enough to establish a New York thesis; partner ownership and sector fit still matter.
How we selected the investors
An investor qualified through a New York City headquarters, a staffed local office, a formal local mandate, or repeated NYC deals. The comparison separates these signals. A global fund with a New York partner may offer local access without investing specifically because a company is based in the city.
We reviewed investor type, stage, sectors, any standardized check disclosed publicly, lead or follow evidence, representative companies, and current activity. Dated fund, deal, program, and portfolio updates are distinguished from current thesis pages. We did not infer check size, reserves, uncalled capital, or deployment pace. State-backed equity is labeled separately from grants and tax incentives.
What this research adds
In New York, volume is the problem: an unfiltered directory creates hundreds of plausible names. Finta retained 15 investors after mapping locality, stage, public check, sector, round role, representative investments, and current activity. The records were rechecked on August 8, 2026, and the order is based on practical founder fit rather than assets or brand recognition.
Investor comparison
| Investor | Type and local basis | Stage and public check | Sectors | Lead or follow evidence | Representative local or regional investments | Current activity status |
|---|---|---|---|---|---|---|
| Union Square Ventures | Venture capital firm. Headquartered in New York City. | Early stage with follow-on support; Not publicly disclosed | Networks, infrastructure, fintech, climate, consumer | Often leads or co-leads early institutional rounds; role varies. | Etsy, MongoDB, Kickstarter | Mandate verified; deployment timing unknown |
| FirstMark | Venture capital firm. Headquartered in New York City. | Seed through growth; Not publicly disclosed | Enterprise, consumer, fintech, health, data | Leads and follows across stages; confirm partner and vehicle. | Ro, Justworks, K Health | Mandate verified; deployment timing unknown |
| Lerer Hippeau | Venture capital firm. Headquartered in New York City. | Pre-seed through Series A; Not publicly disclosed | Consumer, commerce, media, software, health | Frequently invests early and may lead or co-lead. | Warby Parker, Glossier, Casper | Mandate verified; deployment timing unknown |
| Primary Venture Partners | Venture capital firm. Headquartered in New York City with an explicit NYC company focus. | Seed with follow-on support; Not publicly disclosed | B2B software, fintech, health, consumer | Known for concentrated seed investing and active company support; confirm deal role. | Alloy, Chief, K Health | Mandate verified; deployment timing unknown |
| RRE Ventures | Venture capital firm. Headquartered in New York City. | Seed through growth; Not publicly disclosed | Fintech, enterprise, consumer, media, health | Leads and follows; public policy is deal-specific. | Venmo, Noom, BuzzFeed | Mandate verified; deployment timing unknown |
| Greycroft | Venture capital firm. Headquartered in New York City with additional offices. | Seed through growth; Not publicly disclosed | Consumer, enterprise, fintech, health, sustainability | Leads and follows through stage-specific strategies. | Venmo, IEX, Thirty Madison | Mandate verified; deployment timing unknown |
| Insight Partners | Venture capital and growth equity firm. Headquartered in New York City. | Series A through growth, with selected earlier investments; Not publicly disclosed | Software, internet, data, cybersecurity | Frequently leads growth rounds; stage and ownership depend on the strategy. | Dataiku, Wiz, Transmit Security | Mandate verified; deployment timing unknown |
| BoxGroup | Venture capital firm. Headquartered in New York City. | Pre-seed and seed; Not publicly disclosed | Technology, sector agnostic | Usually participates early and can co-lead; not a universal anchor investor. | Flatiron Health, Ro, Ramp | Mandate verified; deployment timing unknown |
| AlleyCorp | Venture capital firm and company builder. Headquartered in New York City. | Pre-seed through Series A; Not publicly disclosed | Healthcare, robotics, enterprise, consumer, civic technology | Creates and leads some companies and invests in others; model varies. | MongoDB, Business Insider, Nomad Health | Mandate verified; deployment timing unknown |
| Eniac Ventures | Venture capital firm. Headquartered in New York City. | Pre-seed and seed; Not publicly disclosed | AI, software, consumer, fintech, health | Often a first institutional investor; lead role is deal-specific. | Hinge, Headway, Attentive | Mandate verified; deployment timing unknown |
| boldstart ventures | Venture capital firm. Headquartered in New York City. | Inception, pre-seed, and seed; Not publicly disclosed | Enterprise infrastructure, cybersecurity, developer tools, SaaS | Frequently leads inception and seed rounds in its specialist categories. | BigID, Kustomer, Snyk | Mandate verified; deployment timing unknown |
| Work-Bench | Venture capital firm. Headquartered in New York City. | Seed; Not publicly disclosed | Enterprise software, infrastructure, cybersecurity, data | Seed specialist that often leads or co-leads; confirm round-specific role. | Cockroach Labs, Spring Health, Socure | Mandate verified; deployment timing unknown |
| Harlem Capital | Venture capital firm. Headquartered in New York City. | Seed and early stage; Not publicly disclosed | Software, consumer, fintech, healthcare, diverse founders | Leads and follows; role varies by round. | Partake Foods, The Folklore, Wagmo | Mandate verified; deployment timing unknown |
| Female Founders Fund | Venture capital firm. Headquartered in New York City. | Pre-seed and seed; Not publicly disclosed | B2B, consumer, fintech, healthcare, climate | Often invests early and may lead or co-lead. | Billie, Zola, Co-Star | Mandate verified; deployment timing unknown |
| New York Angels | Angel investor group. Headquartered in New York City. | Pre-seed and seed; Not publicly disclosed | Technology and scalable businesses across sectors | Member-driven angel syndication; lead behavior varies by deal. | Bombas, Comixology, Enertiv | Mandate verified; deployment timing unknown |
Investor profiles
1. Union Square Ventures
A thesis-led NYC investor with deep experience in network effects and internet platforms.
2. FirstMark
A large NYC platform with a strong founder community and multi-stage reach.
3. Lerer Hippeau
Particularly relevant for consumer, commerce, media, and culture-driven startups.
4. Primary Venture Partners
One of the most locally focused institutional partners for NYC seed founders.
5. RRE Ventures
Longstanding local firm with cross-sector experience and strong institutional networks.
6. Greycroft
Multi-stage support and broad media, consumer, enterprise, and fintech experience.
7. Insight Partners
A strong fit for scaling software companies that need operating support and substantial follow-on capital.
8. BoxGroup
High-volume early-stage network with access to many later-stage firms.
9. AlleyCorp
Deep local operator network and a strong fit for company creation or very early rounds.
10. Eniac Ventures
Focused early-stage support and a strong New York founder network.
11. boldstart ventures
Best fit for deeply technical enterprise founders seeking a specialist first investor.
12. Work-Bench
Enterprise-only focus and direct access to New York corporate buyers.
13. Harlem Capital
Strong local brand and a clear commitment to backing diverse founding teams.
14. Female Founders Fund
A focused option for female-founded technology companies building large markets.
15. New York Angels
One of the city's established formal angel pathways for companies before institutional scale.
How New York City founders should choose investors
- Prioritize firms whose NYC portfolio proves repeat knowledge of your customer and business model.
- For fintech and health, test regulatory, distribution, and buyer expertise rather than relying on a broad sector label.
- At seed, determine whether the investor reserves capital and can help recruit the Series A syndicate.
- For growth investors, lead with retention, efficient growth, and category position rather than a generic market-size slide.
How to access investors in New York City
- Map investors through portfolio founders, startup executives, angels, and customers in the same vertical.
- Use local communities around Cornell Tech, NYU, Columbia, Newlab, company studios, and sector-specific events to build genuine relationships before a raise.
- For enterprise and fintech companies, convert a credible design partner, bank, payer, employer, or regulated customer into investor proof.
- Treat BoxGroup and angel networks differently from firms expected to anchor a priced round. Ask who can set terms and who is participating.
Frequently asked questions
Which NYC firms are strongest at pre-seed and seed?
Lerer Hippeau, BoxGroup, AlleyCorp, Eniac, boldstart, Work-Bench, Harlem Capital, Female Founders Fund, and New York Angels are among the most relevant early options, subject to sector fit.
Which New York investors specialize in enterprise software?
Work-Bench and boldstart are highly focused, while Insight, FirstMark, RRE, Greycroft, and Primary also have substantial enterprise exposure.
Is NYC only strong in fintech?
No. It is unusually strong in fintech, but Carta also places it first in healthtech funding and second in AI and SaaS funding for 2025.
Related Finta investor research
Compare investors by round: Pre-seed investors, seed investors, Series A investors, Series B investors, and Series C investors.
Compare investors by sector: fintech investors, healthtech investors, SaaS investors.
For process guidance, see Finta's pre-seed fundraising guide, seed fundraising guide, and Series A fundraising guide.
Build your personalized investor list with Finta
A city list is a starting point. Finta can rank investors against your company, round, sector, geography, check target, desired round role, and existing network. Use Finta to identify warm paths, research the right partner, manage outreach, share a controlled deal room, and keep every next step in one place.
Editorial review
Written by the Finta Editorial Team and reviewed by Kevin Siskar, CEO of Finta and an early-stage investor and founder-education operator. The review focused on practical stage fit, local access, and claims founders should reconfirm before outreach. This article is general information, not legal, tax, or investment advice.
Sources and verification notes
- Carta, Top Startup Ecosystems of 2025, used for city and sector capital context.
- New York State Comptroller, NYC venture market release, used for independent state market context.
- Empire State Development, venture capital, used to distinguish state-backed equity activity from other public programs.
Every investor name in the comparison table links to an official investor or program source. Each activity-status link points to the dated signal or current mandate source used for that status.
Research disclosure: Last researched and updated August 8, 2026. No investor paid for inclusion. "Not publicly disclosed" means no standardized check was found on the controlling public source. Representative investments establish relevance, not current fit. Confirm the responsible partner, current vehicle, new-investment status, check, ownership, lead behavior, geography, and conflicts directly with the investor before outreach.